Treatment of Childhood Social Phobia

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This 4-year study will compare the long-term effectiveness of behavioral treatment, fluoxetine (Prozac®), and placebo for treatment of social phobia in children and adolescents.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Central Florida
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Fluoxetine

Criteria

Inclusion Criteria:

• Diagnosis of social phobia

Exclusion Criteria:

• Pervasive developmental disorders (PDD)

• Schizophrenia

• Major Depression

• IQ of less than 80

• Medical conditions contraindicating use of fluoxetine